Allianz Asset Management
ADPT icon

Allianz Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Allianz Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.71M Buy
452,537
+72,732
+19% +$1.11M 0.01% 1082
2026
Q1 		$5.27M Buy
379,805
+55,420
+17% +$883K 0.01% 1138
2025
Q4 		$5.27M Buy
324,385
+2,611
+0.8% +$42.6K 0.01% 1119
2025
Q3 		$4.81M Buy
321,774
+242,474
+306% +$2.95M 0.01% 1132
2025
Q2 		$924K Buy
79,300
+66,500
+520% +$604K ﹤0.01% 1687
2025
Q1 		$95.1K Buy
12,800
+100
+0.8% +$769 ﹤0.01% 2177
2024
Q4 		$76.1K Buy
+12,700
New +$70K ﹤0.01% 2156
2022
Q2 		– Sell
-366,290
Closed -$5.08M – 2252
2022
Q1 		$5.08M Sell
366,290
-35,215
-9% -$554K ﹤0.01% 1221
2021
Q4 		$11.3M Sell
401,505
-46,530
-10% -$1.43M 0.01% 951
2021
Q3 		$15.2M Sell
448,035
-17,694
-4% -$640K 0.01% 839
2021
Q2 		$19M Buy
465,729
+405,482
+673% +$15.8M 0.02% 663
2021
Q1 		$2.42M Sell
60,247
-351,887
-85% -$19M ﹤0.01% 1337
2020
Q4 		$24.4M Buy
412,134
+105,569
+34% +$5.44M 0.02% 549
2020
Q3 		$14.9M Buy
306,565
+60,860
+25% +$2.56M 0.02% 659
2020
Q2 		$11.9M Buy
245,705
+224,347
+1,050% +$8.18M 0.01% 819
2020
Q1 		$593K Sell
21,358
-13,039
-38% -$364K ﹤0.01% 1987
2019
Q4 		$1.03M Sell
34,397
-28,174
-45% -$809K ﹤0.01% 2183
2019
Q3 		$1.93M Sell
62,571
-141,234
-69% -$5.76M ﹤0.01% 1837
2019
Q2 		$9.84M Buy
+203,805
New +$9.03M 0.01% 1199

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allianz Asset Management's ADPT Position: Q2 2026 in Review

Allianz Asset Management increased its Adaptive Biotechnologies (ADPT) stake by 19% in Q2 2026, buying an estimated $1.11M and bringing the position to 452,537 shares worth $9.71M. The position accounts for 0.01% of the portfolio, ranked #1082.

Allianz Asset Management first reported a position in ADPT in Q2 2019 and has held it in 19 quarters since. The position peaked at $24.4M in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Allianz Asset Management held 452,537 shares of Adaptive Biotechnologies worth $9.71M as of Q2 2026.
  • Allianz Asset Management bought 72,732 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.11M.
  • Adaptive Biotechnologies made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1082 holding.
  • Allianz Asset Management first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 19 quarters since.
  • Allianz Asset Management's Adaptive Biotechnologies position peaked at $24.4M in Q4 2020.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.